Citalopram is one of the most selective serotonin reuptake inhibitors (SSRIs), used for major depressive disorder and anxiety disorders, with a straightforward pharmacokinetic profile and limited drug-drug interactions relative to older antidepressants. Simson Pharma's Citalopram reference standard and impurities support the high-volume compendial testing this widely prescribed antidepressant requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Citalopram Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.